Tops & Flops Stocks
Security | Change (%) | 1w ▼ | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Amgen Inc. | 10.960% | 14.603% | 14.150% | 39.306% | 10.975% | 42.148% | 83.108% |
Blueprint Medicines Corp | 0.800% | 14.496% | 16.835% | 111.745% | 20.630% | 24.931% | - |
Eledon Pharmaceuticals Inc. | -2.780% | 13.514% | 22.093% | -0.943% | 28.049% | -74.850% | -95.135% |
Corbus Pharmaceuticals Holding Inc. | 4.620% | 13.376% | 0.565% | 27582.737% | 27582.737% | -17.045% | - |
Cara Therapeutics Inc. | 0.700% | 13.166% | -15.009% | -80.518% | 4.110% | -93.339% | -95.935% |
Intellia Therapeutics Inc | 1.470% | 13.026% | -5.028% | -37.275% | -24.318% | -64.164% | 62.236% |
Aclaris Therapeutics Inc | 2.710% | 13.016% | 8.675% | -84.164% | 32.526% | -93.638% | - |
Celldex Therapeutics | 5.680% | 12.353% | -0.521% | 16.463% | 5.525% | 50.512% | 619.397% |
Compugen Ltd. | 7.980% | 12.011% | -8.028% | 261.261% | 23.006% | - | - |
Adaptimmune Therapeutics PLC ADR | 0.900% | 12.000% | -11.111% | -11.111% | 79.200% | -76.170% | - |
Glycomimetics Inc. | -0.880% | 11.649% | -33.229% | 38.250% | -24.513% | -14.271% | - |
Fibrogen Inc. | -1.670% | 11.469% | -22.033% | -93.063% | 22.616% | -94.225% | - |
BioLine RX Ltd ADR | -3.230% | 11.404% | -17.532% | -34.536% | -55.282% | -76.128% | -99.113% |
Enanta Pharmaceuticals Inc. | - | 11.404% | -15.894% | -60.063% | 44.318% | -70.602% | -83.479% |
Anavex Life Sciences Corp | 0.830% | 10.962% | -15.408% | -52.858% | -58.914% | -64.191% | 42.520% |
Rhythm Pharmaceuticals | 3.140% | 10.929% | 7.407% | 141.667% | -4.695% | - | - |
Daiichi Sankyo Co Ltd | 0.060% | 10.925% | 14.919% | 7.618% | 34.141% | 53.562% | - |
United Therapeutics | -0.080% | 10.773% | 14.199% | 23.424% | 22.926% | 43.353% | 172.961% |